Literature DB >> 23040838

β-Adrenergic regulation of the cardiac Na+-K+ ATPase mediated by oxidative signaling.

Keyvan Karimi Galougahi1, Chia-Chi Liu, Henning Bundgaard, Helge H Rasmussen.   

Abstract

Activation of β-adrenergic receptors (ARs) elicits responses arising from protein kinase A (PKA)-mediated phosphorylation of target proteins that regulate Ca(2+)-dependent excitation-contraction coupling. Some important targets for β-AR- and PKA-dependent pathways, including the sarcolemmal Na(+)-K(+) pump, also undergo oxidative modifications in response to activation of receptor-coupled redox signaling pathways in cardiac myocytes. Here, we highlight how β(1)- and β(3)-AR signaling have opposing effects on functionally important oxidative modification of the Na(+)-K(+) pump molecular complex and how the addition of redox dependence to the canonical phosphorylation dependence of the scheme for β-AR signaling in general expands its versatility but also its complexity. The expanded scheme integrates increased oxidative stress into the pathophysiological effects of adrenergic hyperactivity and provides mechanistic explanation for the efficacy of β-AR blockers in heart failure in which raised intracellular Na(+) levels are detrimental-an explanation not provided by traditionally held views on β-AR-mediated regulation of the pump function. Crown
Copyright © 2012. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23040838     DOI: 10.1016/j.tcm.2012.06.017

Source DB:  PubMed          Journal:  Trends Cardiovasc Med        ISSN: 1050-1738            Impact factor:   6.677


  9 in total

1.  β3-Adrenoceptor activation relieves oxidative inhibition of the cardiac Na+-K+ pump in hyperglycemia induced by insulin receptor blockade.

Authors:  Keyvan Karimi Galougahi; Chia-Chi Liu; Alvaro Garcia; Natasha A Fry; Elisha J Hamilton; Gemma A Figtree; Helge H Rasmussen
Journal:  Am J Physiol Cell Physiol       Date:  2015-06-10       Impact factor: 4.249

2.  The Concise Guide to PHARMACOLOGY 2013/14: transporters.

Authors:  Stephen P H Alexander; Helen E Benson; Elena Faccenda; Adam J Pawson; Joanna L Sharman; Michael Spedding; John A Peters; Anthony J Harmar
Journal:  Br J Pharmacol       Date:  2013-12       Impact factor: 8.739

Review 3.  Pathophysiological mechanisms of catecholamine and cocaine-mediated cardiotoxicity.

Authors:  Lucas Liaudet; Belinda Calderari; Pal Pacher
Journal:  Heart Fail Rev       Date:  2014-11       Impact factor: 4.214

4.  Protein kinase-dependent oxidative regulation of the cardiac Na+-K+ pump: evidence from in vivo and in vitro modulation of cell signalling.

Authors:  Keyvan Karimi Galougahi; Chia-Chi Liu; Alvaro Garcia; Natasha A S Fry; Elisha J Hamilton; Helge H Rasmussen; Gemma A Figtree
Journal:  J Physiol       Date:  2013-04-15       Impact factor: 5.182

5.  β 3 Adrenergic Receptor Stimulation Promotes Reperfusion in Ischemic Limbs in a Murine Diabetic Model.

Authors:  Kristen J Bubb; Dhanya Ravindran; Siân P Cartland; Meghan Finemore; Zoe E Clayton; Michael Tsang; Owen Tang; Mary M Kavurma; Sanjay Patel; Gemma A Figtree
Journal:  Front Pharmacol       Date:  2021-04-22       Impact factor: 5.810

6.  β3 Adrenergic Stimulation Restores Nitric Oxide/Redox Balance and Enhances Endothelial Function in Hyperglycemia.

Authors:  Keyvan Karimi Galougahi; Chia-Chi Liu; Alvaro Garcia; Carmine Gentile; Natasha A Fry; Elisha J Hamilton; Clare L Hawkins; Gemma A Figtree
Journal:  J Am Heart Assoc       Date:  2016-02-19       Impact factor: 5.501

Review 7.  Targeting β3-Adrenergic Receptors in the Heart: Selective Agonism and β-Blockade.

Authors:  Alessandro Cannavo; Walter J Koch
Journal:  J Cardiovasc Pharmacol       Date:  2017-02       Impact factor: 3.105

8.  Protocol for the Stimulating β3-Adrenergic Receptors for Peripheral Artery Disease (STAR-PAD) trial: a double-blinded, randomised, placebo-controlled study evaluating the effects of mirabegron on functional performance in patients with peripheral arterial disease.

Authors:  Kristen J Bubb; Jason A Harmer; Meghan Finemore; Sarah Joy Aitken; Zara S Ali; Laurent Billot; Clara Chow; Jonathan Golledge; Rebecca Mister; Michael P Gray; Stuart M Grieve; Naomi Hamburg; Anthony C Keech; Sanjay Patel; Vikram Puttaswamy; Gemma A Figtree
Journal:  BMJ Open       Date:  2021-09-28       Impact factor: 2.692

9.  Migraine-Associated Mutation in the Na,K-ATPase Leads to Disturbances in Cardiac Metabolism and Reduced Cardiac Function.

Authors:  Christian Staehr; Palle Duun Rohde; Nikolaj Thure Krarup; Steffen Ringgaard; Christoffer Laustsen; Jacob Johnsen; Rikke Nielsen; Hans Christian Beck; Jens Preben Morth; Karin Lykke-Hartmann; Nichlas Riise Jespersen; Denis Abramochkin; Mette Nyegaard; Hans Erik Bøtker; Christian Aalkjaer; Vladimir Matchkov
Journal:  J Am Heart Assoc       Date:  2022-03-15       Impact factor: 6.106

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.